Cannlabs Inc (CANL)
CannLabs, Inc. is a common stock listing on OTC Markets under the symbol CANL. The company provides cannabis testing laboratory services in the United States, with testing capabilities that cover potency, residual solvents, microbiological contaminants, pesticides, heavy metals, nutrients, terpenes, shelf-life and stability studies, as well as gene expression and genotyping or phenotyping testing. In addition to laboratory work, CannLabs also provides data and analytics, consulting, and education services. The company was incorporated in 2010 and is based in Denver, Colorado.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CANL
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
94.216 K
|
—
|
—
|
—
|
—
|
—
|
—
|